Acadia Pharmaceuticals (ACAD) Income towards Parent Company (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted Income towards Parent Company of $31.5 million for Q2 2026, up 761.6% on a QoQ basis from $3.7 million in Q1 2026, and up 18.13% year-over-year from $26.7 million in Q2 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Income towards Parent Company (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals has reported Income towards Parent Company for 17 years, with the latest figure at $31.5 million in Q2 2026.
- On a quarterly basis, Income towards Parent Company rose 18.13% year-over-year to $31.5 million in Q2 2026; TTM through Jun 2026 was $380.5 million, a 90.63% increase from a year earlier, with the FY2025 full-year figure at $391.0 million, up 91.78% from the prior year.
- Income towards Parent Company was $31.5 million for Q2 2026 at Acadia Pharmaceuticals, up from $3.7 million in the prior quarter.
- The five-year high for Income towards Parent Company was $273.6 million in Q4 2025, with the low at -$113.1 million in Q1 2022.
- Average Income towards Parent Company over 5 years is $23.4 million, with a median of $17.8 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Income towards Parent Company sank 139.49% in 2023, then jumped 2898.2% in 2024.
- Over 5 years, Income towards Parent Company stood at $5.7 million in 2022, then soared by 1075.65% to $66.8 million in 2023, then surged by 81.5% to $121.2 million in 2024, then jumped by 125.74% to $273.6 million in 2025, then tumbled by 88.48% to $31.5 million in 2026.
- The last three Income towards Parent Company figures came in at $31.5 million (Q2 2026), $3.7 million (Q1 2026), and $273.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Acadia Pharmaceuticals | 4.38 Bn | 3.42 Bn | 279.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.50 Mn |
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | 273.55 Mn |
| Sep 30, 2025 | 71.80 Mn |
| Jun 30, 2025 | 26.67 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | 121.18 Mn |
| Sep 30, 2024 | 32.77 Mn |
| Jun 30, 2024 | 33.40 Mn |
| Mar 31, 2024 | 16.56 Mn |
| Dec 31, 2023 | 66.77 Mn |
| Sep 30, 2023 | -65.18 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | -43.02 Mn |
| Dec 31, 2022 | 5.68 Mn |
| Sep 30, 2022 | -27.22 Mn |
| Jun 30, 2022 | -34.04 Mn |
| Mar 31, 2022 | -113.10 Mn |
| Dec 31, 2021 | -7.56 Mn |
| Sep 30, 2021 | -14.46 Mn |
API Access
Acadia Pharmaceuticals Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();